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Abstract
Purpose Research on venous thromboembolism events
(VTE), such as deep venous thrombosis (DVT) and pul-
monary embolism (PE), in pediatric orthopaedic trauma
patients is sparse. We describe the incidence in the USA of
VTE associated with pediatric lower extremity orthopaedic
trauma, and characterize injury patterns and VTE treatment
methods.
Methods The Pediatric Health Information System
(PHIS) was queried from 2004 to 2013 using ICD-9 codes
for lower extremity fractures (pelvis, femur, tibia, ankle,
foot) and dislocations (hip, knee, ankle, subtalar) and VTE.
Records were queried for age, diagnoses, and VTE
treatment.
Results During the study period 285,611 clinical
encounters reported lower extremity trauma. Of those, 167
patients were simultaneously coded with VTE (99 DVT, 50
PE, 18 combined DVT/PE), to give an incidence of VTE
associated with pediatric lower extremity trauma of
0.058 %. Patients were from 39 centers, with an average
age of 12.9 years (range 0–19). There were 249 fractures
and 21 dislocations, with 25 (15 %) patients sustaining
more than one lower extremity injury. The most common
fracture locations were the femur/femoral neck (95), tibia/
ankle (92), and pelvis (44). 72 % (121/167) of patients
were treated with anticoagulation medication, of which the
most common was low-molecular-weight heparin (111/
167, 66 %).
Conclusions The incidence of VTE events associated
with lower extremity orthopaedic trauma is 0.058 %.
Adolescents and polytrauma patients with injuries of the
femur/femoral neck, tibia/ankle, and pelvis are more
commonly affected. Low-molecular-weight heparin is
commonly used to treat VTE in pediatric and adolescent
patients.
Keywords Venous thromboembolism  Pediatric
orthopaedics  Trauma  Lower extremity  Fracture
Introduction
Venous thromboembolism events (VTE) include deep
venous thrombosis (DVT) and pulmonary embolism (PE).
In adults, orthopaedic procedures and traumatic injuries are
known risk factors for VTE [1–3], while traumatic injuries,
infections, and central venous catheters have also been
linked to VTE in pediatric patients [4, 5].
Current literature regarding VTE in children with
orthopaedic trauma is limited by small cohorts of patients
[6] or survey responses [7, 8]. Recently, data on VTE
associated with elective orthopaedic procedures has been
published [9], but there is no national data in the USA on
VTE events associated with pediatric orthopaedic trauma.
The primary purpose of this study was to report the
incidence of VTE associated with pediatric orthopedic
lower extremity trauma. We also reviewed the injury
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locations and treatment methods for VTE in this patient
population.
Methods
Following Institutional Review Board approval, the Pedi-
atric Health Information System (PHIS) was queried from
2004 to 2013. PHIS is an administrative database that
contains inpatient, emergency department, ambulatory
surgery, and observation encounter-level data from over 45
pediatric hospitals in the United States. Records are de-
identified at the time of data submission, and data are
subjected to a number of reliability and validity checks
before being included in the database. We searched for all
patient encounters with simultaneous coding of lower
extremity orthopaedic trauma and a lower extremity DVT
and/or a pulmonary embolus. (See Table 1 for ICD-9
codes).
Results
From 2004 to 2013, there were 36,524,804 unique
encounters submitted to the PHIS database, of which
285,611 contained a diagnosis of orthopaedic lower
extremity trauma (0.7 %). Of these cases, 167 qualified for
inclusion with a concomitant diagnosis of VTE during the
same encounter. This represents an incidence of 0.00046 %
associated with all clinical encounters, and an incidence of
0.058 % (95 % confidence interval = 0.050–0.068 %)
specifically associated with orthopaedic lower extremity
trauma. The average age at diagnosis was 12.9 years (range
0–19). The cohort of patients came from 39 different
institutions across the United States.
One hundred and forty-two of the 167 patients sustained
an isolated orthopaedic trauma injury, and 25 (15 %)
patients were polytrauma patients with multiple diagnoses
(range 2–4), to give a total of 270 lower extremity ortho-
paedic injuries. The injury distribution of fractures was as
follows: pelvis/acetabulum (44), femoral neck (14),
femoral shaft (81), tibia (61), and ankle/foot (49). The
distribution of dislocations was hip (7), knee (13), and
ankle (1). Figure 1 lists the injuries by type and anatomic
distribution.
One hundred and twenty-one of the 167 (72 %) patients
had at least one anticoagulant simultaneously coded with
VTE and lower extremity orthopaedic trauma. One hun-
dred and eleven (66 %) patients were treated with low-
molecular-weight heparin, 28 (17 %) were treated with
warfarin, and 11 (7 %) were treated with aspirin. Twenty-
four patients (14 %) had more than one anticoagulant
coded during the encounter.
Discussion
Venous thromboembolism events in children are rare.
Known risk factors include placement of a central venous
catheter, obesity, trauma, and infection [4, 5, 10]. Rates of
incidence of VTE in hospitalized children are increasing
over time [11], with up to 58 cases reported per 10,000
hospital admissions [12]. In the general pediatric trauma
population, the published incidence rates of VTE range
from 0.02 to 0.26 % [13–15].
Georgopoulos et al. [8] used the PHIS database to cal-
culate the incidence of VTE events associated with elective
pediatric orthopaedic surgery [8]. They found a total of 71
cases over a 6-year time period within approximately
143,000 admissions, which corresponded to an incidence of
Table 1 ICD-9 codes used to query the PHIS database for VTE
events and lower extremity trauma
DVT 453.40, 453.41, 453.42
PE 415.1
Pelvic fracture 808.*
Femur fracture 821.* and 820.*
Tibia fracture 823.* and 824.*
Ankle fracture 824.*





Fig. 1 Distribution of lower extremity fractures (left side, red) and
dislocations (right side, blue) associated with venous
thromboembolism
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0.015 %. Greenwald et al. [4] reviewed all cases of pelvic
and femoral fractures at their institution, and found a total
of three cases of DVT during a 20-year time period, and
reported a prevalence of 0.17 %. Our reported incidence of
VTE after lower extremity orthopaedic trauma of 0.058 %
is comparable with these two previous studies, reflecting
consistent trends in VTE events over time.
In our series, the most common location for a lower
extremity injury associated with VTE was a femur/femoral
neck fracture, accounting for 40 % (95/270) of all injuries.
Other common locations included fractures of the tibia/
ankle, and fractures of the pelvis and acetabulum. This
finding supports previous work which found that pediatric
patients with lower extremity fracture are at increased risk
for VTE [10]. Sabharwal and coauthors [5] surveyed
members of the Pediatric Orthopaedic Society of North
America, reporting first a preliminary survey of clinical
experience with VTE in pediatric orthopaedic patients. In
their study, more than half of the respondents could recall
at least one case of DVT during their career. In a follow-up
survey, Sabharwal et al. [6] reported on 46 children who
suffered a VTE event as result of either trauma or elective
orthopedic surgery. Most VTE events were associated with
lower extremity procedures, such as osteotomies and fixa-
tion of a long-bone fracture.
Treatment for VTE commonly includes anticoagulation
with low-molecular-weight heparin (LMWH), warfarin, or
aspirin. We found that almost 75 % of patients in our
cohort had an anticoagulant simultaneously coded with
VTE and orthopaedic injury. Most treated patients received
LMWH, and others also received warfarin or aspirin. The
national data in our series confirms previously published
work from the PHIS database from 2001 to 2008 which
found that use of LMWH (enoxaparin) has been increasing
in pediatric trauma patients [14]. Furthermore, the majority
of providers in Sabharwal et al.’s survey reported using
LMWH to treat VTE in pediatric orthopaedic patients [9].
Several limitations exist in this study. While there is
merit in using databases such as the PHIS to report on a
large volume of patients, there are inherent weaknesses
with the accuracy of this database. It is possible that our
reported incidence is an underestimation of the true inci-
dence of VTE associated with pediatric orthopedic trauma,
as it is likely that not all cases of VTE were reported or
correctly coded. However, despite these limitations we
believe that important conclusions can be drawn from this
study.
In conclusion we describe the presentation and inci-
dence of pediatric VTE across the United States associ-
ated with lower extremity orthopaedic trauma. The
incidence of VTE after pediatric orthopaedic trauma is
low and appears to be commonly associated with fractures
of the femur, tibia, and pelvis/acetabulum. From our
analysis, adolescents (C12 years) appear to experience a
higher incidence of VTE than infants and children. Clin-
icians caring for children and adolescents after ortho-
paedic lower extremity trauma should be aware of the risk
of VTE.
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